Description
Composition- Glimepiride 4 mg + Metformin HCl 1000 mg ER
Mode of Action- Maximizes insulin secretagogue effect along with prolonged metformin-mediated glucose control.
USPs- High-potency dual combination; extended-release support; ideal for poorly controlled type 2 diabetes.
Prescribing Specialties- Diabetologist, Internal Medicine
